headache - migraine disorders - menopause - women
cefaleia - transtornos de enxaqueca - menopausa - mulheres
The reproductive lifecycle of women with migraine has always been a subject of interest[1]. The menarche, menses, pregnancy, post-natal and menopausal periods are all associated
with different degrees and frequency of migraine[2]. While there is a lay concept that migraine will improve after the menopause, this
is unfortunately not true. Migraine is a multifactorial disorder and it would be very
simplistic to consider it to be related exclusively to hormonal cycles. Headache clinics,
particularly within tertiary care, receive many women whose migraines have not improved,
have worsened or have even started after menopause. Hormonal replacement therapy does
not seem to be a good therapeutic option for all women, since many of them report
worsening of their migraine after starting hormone replacement.
A very recent systematic review on the subject of migraine and menopause[3] identified 22 relevant studies showing that migraine is reported by 10% to 29% of
menopausal women. The authors of the systematic review concluded that migraine prevalence
remains stable or increases after the menopause. While population-based studies showed
a tendency towards less severe migraines after menopause, data from tertiary clinics
showed stable or worse migraine attacks after menopause[3]. In the same review, the authors identified only three papers addressing perimenopausal
symptomatology and the results were not uniform. One study with over 700 patients
from a headache clinic showed no clear relationship between migraine and the menopause
syndrome[4]. A population-based longitudinal study showed that it was only during the menopausal
transition that a clear pattern of migraine and menopausal symptoms could be observed[5]. A very large population-based longitudinal cohort showed that, in fact, perimenopausal
symptomatology seems to be determined by multifactorial aspects of socioeconomic,
demographic, reproductive and lifestyle parameters among these women[6]. The present study reports on mood disorders, menopausal symptoms and labor disability
in menopausal women.
METHODS
The project was approved by the Ethics Committee of Universidade Metropolitana de
Santos, under the number CAAE 46032715700005509. Confidentiality was guaranteed for
the patients, who signed a statement consenting to voluntary participation in the
study of the menopausal syndrome. The aim of the study (assessment of primary headaches)
was not disclosed at this point, in order to avoid bias in the selection of patients.
Menopausal patients attending public gynecological outpatient healthcare services
in Santos, Sao Vicente, Praia Grande and Cubatão (all of which are cities in the coastal
region of the State of Sao Paulo, Brazil) were invited to take part in this project.
The critical inclusion criteria were that the patients needed to present with a natural
(non-surgical) menopause, without having had hormone replacement therapy at any time
(their own choice). Those who fulfilled these criteria and were willing to participate
were interviewed individually. The interview focused on the presence and characteristics
of headaches at any time in their lives (primary outcome). Regarding secondary outcomes,
all participants were screened for anxiety and/or depression traits using the Hospital
Anxiety and Depression Scale[7] and for the menopause syndrome by means of the Menopause Rating Scale[8]. This scale takes into account many aspects of menopausal symptoms such as cognition,
mood disorders, worries, quality of sleep, pain, urogenital complaints and sexual
satisfaction. Socioeconomic level was assessed using the Brazilian rating system from
the Instituto Brasileiro de Geografia e Estatística. According to this system, socioeconomic
classes range from A1 (highest) to E (lowest).
Depending on the characterization of the headache, the patients were divided into
three groups: no headache, migraine, and other headache (non-migraine). The diagnosis
of migraine was obtained in accordance with the criteria from the International Headache
Society[9] and these patients answered the Migraine Disability Assessment (MIDAS) questionnaire[10], which has been validated in Brazil[11]. The MIDAS questionnaire establishes the degree of disability and treatment requirements
for migraine over the last three-month period. The effect of migraine on disability
and the urgency of adequate treatment can be scored as mild, moderate or severe.
Statistical analyses were performed blindly, and variables were analyzed by means
of the Mann Whitney test for comparison of the three groups regarding headache pre-
and post-menopause, anxiety and depression, menopausal symptoms and socioeconomic
level. Spearman’s correlation test and ANOVA were used for assessing the potential
correlation among values for MIDAS, menopause symptoms, anxiety and/or depressive
traits. A 95% confidence interval was established and values were considered to be
significant if p < 0.05. Sample size calculation established n = 88 for this population
of patients.
RESULTS
One hundred and three women attending gynecology outpatient services in connection
with menopause, in cities of the coastal region of the State of Sao Paulo, agreed
to take part in this survey. The average age of these patients was 54.2 ± 3.0 years,
and the average period that had elapsed since the last menstrual period was 7.0 ±
4.5 years. The socioeconomic level of this population attending public healthcare
services ranged from A to D, and was, on average, classified as C1, which is representative
of the Brazilian population as a whole.
From the whole group of menopausal women, 86.2% reported a history of some type of
headache [tension type headache (71.8%), unclassifiable facial or cranial pain (9.7%)],
and 14.7% had migraine[9]. Demographic data on the patients in the three groups (migraine, non-migraine headache
and no headache) are presented in [Table 1]. In summary, there were no significant differences regarding the patients’ ages,
time elapsed since menopause and socioeconomic classes among the groups. After menopause,
61.8% of the patients did not have any change to, or improvement of, their headaches,
while 38.2% of them had worse headaches.
Table 1
Characteristics of patients without headache, with non-migraine headache and with
migraine after menopause.
|
Variable
|
N
|
%
|
Age at menopause
|
Present age
|
Worsening of headache after menopause
|
Anxiety trait
|
Depression trait
|
Hauser (average)
|
|
|
|
n (%)
|
n (%)
|
n (%)
|
|
Total group of patients
|
103
|
-
|
46.7 ± 5.0
|
51.2 ± 3.1
|
33 (38.2)
|
23 (22.3)
|
11 (10.7)
|
4.9 ± 1.8
|
|
No headache
|
14
|
13,5
|
45.7 ± 4.9
|
53.3 ± 3.1
|
-
|
1 (7.1)
|
0
|
4.5 ± 1.3
|
|
Non-migraine headache
|
74
|
71,8
|
47.6 ± 4.4
|
54.4 ± 3.0
|
27 (26.5)
|
15 (20.3)
|
8 (10.8)
|
4.9 ± 1.8
|
|
Migraine
|
15
|
14,7
|
44.8 ± 6.0
|
53.5 ± 3.5
|
6 (40)
|
7 (46.6)
|
3 (20)
|
5.5 ± 2.5
|
The length of time for which the menopausal women with migraine had been presenting
with this was 23 years, and none presented with headache starting at or after menopause.
However, 39% of the patients reported worsening of migraine after the last menstrual
period (p = 0.05). Regarding frequency of migraine, 28.6% of the women reported having
two or more attacks per month, and 3.8% of these presented with chronic migraine with
more than 15 days of pain per month.
Data on the patients with migraine are presented in [Table 2]. The disability due to migraine was considered mild in 66.7% of the women, moderate
in 26.7% and severe in 6.6%. The women with migraine had significantly higher levels
of anxiety and depressive traits (p = 0.01), as well as more menopausal symptoms (p
= 0.00). There were no significant differences regarding socioeconomic levels among
the patients in the three groups. It is interesting to notice that the women with
other forms of headache (non-migraine) had intermediate levels of anxiety, depression
and menopausal symptoms, in comparison with the migraine patients and the controls
without any headache. These data are summarized in [Table 1].
Table 2
Results of disability caused by Migraine Disability Assessment10,11. There were 15
patients with migraine (out of 103 women) in this study.
|
MIDAS
|
Disability
|
Therapy
|
Number of patients
|
Percentage
|
|
0 to 5
|
Minimal
|
Smal or no need
|
6
|
40.0%
|
|
6 to 10
|
Mild or infrequent
|
Moderate need
|
4
|
26.7%
|
|
11 to 20
|
Moderate
|
Requires
|
4
|
26.7%
|
|
> 21
|
Severe
|
Requires urgent
|
1
|
6.6%
|
Disability caused by migraine is summarized in [Table 2]. One third of the patients with migraine required adequate management and therapy,
as shown through MIDAS. The MIDAS score was correlated with the score for depressive
traits (p = 0.01). The MIDAS questionnaire is specific for assessing migraine burden
and, therefore, was not used to assess the burden of non-migraine headaches in this
study.
DISCUSSION
Menopause is a period of great changes to women’s bodies and minds. Alterations to
body image and emotions, psychological adjustment to a new phase of life and worries
about the higher prevalence of severe diseases and cognitive dysfunction all contribute
towards negatively affecting the quality of life of menopausal patients[12],[13]. Symptoms that are typical of hormonal deprivation and aging are prevalent and distressful
to many, often requiring individual counseling and specific therapies[14]. Some of the symptoms are manageable and headache is certainly a modifiable parameter
if given the appropriate treatment. In the present series, about one third of the
women had experienced worsening of their primary headaches after their last menstrual
period, which contradicts the popular belief that “after menopause the headache gets
better”.
Many women believe that the burden of their migraine will finish at menopause but
this is, unfortunately, not the case for many. In the present study, the prevalence
of migraine after menopause was similar to that found by other authors[3] and nearly a quarter of the postmenopausal women in our series had migraine attacks.
This result is in agreement with a recent expert consensus on the matter[15]. The majority of the cases of migraine in this series did not show severe disability.
However, the results from MIDAS point towards the fact that the lives of a considerable
number of women are disrupted by the burden of migraine, resulting in missing days
of work, housework and leisure time due to their headache attacks. The MIDAS values,
in this population, are similar to that of Brazil as a whole[16]. Higher levels of anxiety, depressive traits, menopause symptomatology and intensity
of headache pain in attacks were all significant for post-menopausal women with migraine.
There are limitations to the present work, particularly due to the relatively small
population of women with migraine assessed here. However, the prevalence of migraine
found in the patients enrolled in this study is in accordance with the literature[3],[16] and the increased symptomatology is also in line with a recent systematic review
of the subject[3]. Therefore, even if the final number of women with migraine in the study is not
high, they seem to be representative of this population of patients. In addition,
another limitation to the study was the short follow-up of these menopausal women,
in the order of seven years on average. Women may live a third of their lives in the
post-menopausal period and different stages of this condition should be assessed as
well. It is possible that, after 20 or 25 years of menopause, women may show different
findings to these reported here. Further studies should address the methodological
pitfalls of the present study.
In conclusion, in a population of women with natural non-surgical menopause and without
hormone therapy replacement, the burden of migraine often persists after menopause.
Other associated psychiatric and gynecological symptoms increase the disability in
these women. These factors are potentially modifiable.
